Provided are skincare compositions that include a bactericide, one or more surfactants, water, and optionally saturated fatty acid. The composition may include a bactericide, surfactants (e.g., anionic and/or zwitterionic), saturated fatty acid, and no more than about 50 wt % water. Alternatively, the composition may include a bactericide, surfactants (e.g., anionic and/or nonionic), and at least about 50 wt % water. Commonly, the skincare compositions may include benzoyl peroxide and goat milk. The compositions may be used for various applications including cleaning the skin and as a shaving cream.

The basis to develop a cosmetic and pharmaceutical composition based on a combinatorial derivative of quercetin in the form of nanoparticles (liposomes) for the treatment of atherosclerosis and its complications, as well as hypertension, for rejuvenating the body and healing wounds. The problem is solved by obtaining a cosmetic and pharmaceutical composition based on a combinatorial quercetin derivative, characterized in that the modified combinatorial quercetin derivative is represented as a combinatorial library (mixture) of quercetin derivatives obtained by simultaneous combinatorial modification of quercetin with at least two alkylating and acylating modifiers in the combinatorial reaction synthesis to obtain the maximum number of different derivatives of quercetin, and as biologically active substances, a whole combinatorial mixture of quercetin derivatives is used without separation into individual components to create cosmetic and pharmaceutical compositions.

The present invention relates to a novel use of milk exosomes, and more specifically, provides a method of inhibiting UV-induced oxidative damage of cells using an effective amount of exosomes isolated from milk or goat milk.

Described herein are compositions comprising an extract from Hibiscus genus and an extract from damaged plant parts from the Moringaceae genus, and methods for stimulating collagen synthesis in skin cells. Also described herein are compositions comprising an extract from Hibiscus genus, an extract from damaged plant parts from the Moringaceae genus, and a complex of actives comprising at least one oligopeptide, at least one extract from the Laminaria genus, and whey protein.

The present invention provides a pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis or modifying hair, the pharmaceutical composition comprising a therapeutically effective amount of a saturated fatty acid or a pharmaceutically acceptable salt thereof as an active ingredient.

The present invention provides a pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis or modifying hair, the pharmaceutical composition comprising a therapeutically effective amount of a saturated fatty acid or a pharmaceutically acceptable salt thereof as an active ingredient.

The present invention relates to the use of a milk whey protein hydrolysate for preventing or treating transepidermal water loss (TEWL) and/or TEWL-associated disorders or/and enhancing skin barrier function in young and adult mammals. The protein hydrolysate may be used in the prevention or treatment of TEWL-associated disorders, such as atopic dermatitis, dry or reactive skin or skin dehydration. It may also be used in the cosmetic use of improving skin appearance.

The invention concerns a composition for cosmetic or dermatological use comprising an iron-binding glycoprotein and a casein hydrolysate, and optionally comprising colostrum, a precursor of nitric oxide, an antioxidant and serotonin or one of the precursors thereof.

Solid cleansing compositions and methods for the same are disclosed herein. The solid cleansing compositions may include a soap, a plant oil, and a hydrolyzed protein. The plant oil and the hydrolyzed protein may be present in an effective amount to maintain or increase hydration of skin. The plant oil may be or include a flaxseed oil, and the hydrolyzed protein may be or include a hydrolyzed milk protein.

A composition and method for administering an active agent to a pet, such as a dog, a cat or a horse. The composition may comprise a yogurt-based chewable delivery matrix and a plurality of water-soluble film pieces dispersed throughout the chewable delivery matrix. The composition may also comprise a delivery matrix having at least 15% by weight of crude protein and a plurality of water-soluble film pieces dispersed throughout the delivery matrix. The plurality of water-soluble film pieces encompass an active agent therein, wherein the active agent is rapidly released from the composition upon contact with saliva from the pet. At least a portion of the released active agents may be oromucosally absorbed by the pet.